Pharmacy

RALISTA Evista

Home » Prescription Drugs 14 » RALISTA Evista

Raloxifene is used for: Treating and preventing osteoporosis (bone thinning) in women past menopause. Ralista is prescribed to treat and prevent osteoporosis the brittle-bone disease that strikes some women after menopause. A variety of factors promote osteoporosis. The more factors that apply to you the greater your chances of developing the disease. These factors include:Caucasian or Asian descentSlender buildEarly menopauseSmokingDrinkingA diet low in calciumAn inactive lifestyleOsteoporosis in the familyRaloxifene affects the cycle of bone formation and breakdown in the body and reduces loss of bone tissue. Raloxifene is used to treat or prevent osteoporosis in postmenopausal women. Raloxifene is also used to reduce the risk of invasive breast cancer in postmenopausal women who have osteoporosis or who are otherwise at risk of invasive breast cancer.

Buy RALISTA Evista and other Prescription Drugs 14 products online at Medstore.

Buy Online at Medstore - Click Here!

About RALISTA Evista:

Product Type: Prescription Drugs 14

RALISTA ( Evista Generic Raloxifene )

RALISTA (Evista Generic Raloxifene)

Evista Generic Raloxifene

60mg Evista Generic Raloxifene RALISTA

View more Prescription Drugs 14

Previous Product  Next Product

Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.